Cart
sales@molnova.com
euphorbiafactor L2
CAS No. 218916-51-9
euphorbiafactor L2( —— )
Catalog No. M20416 CAS No. 218916-51-9
Euphorbiafactor?L2?alleviates lipopolysaccharide-induced acute lung injury and inflammation through inhibits NF-κB activation.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 171 | In Stock |
|
| 10MG | 250 | In Stock |
|
| 25MG | 422 | In Stock |
|
| 50MG | 620 | In Stock |
|
| 100MG | 885 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Nameeuphorbiafactor L2
-
NoteResearch use only, not for human use.
-
Brief DescriptionEuphorbiafactor?L2?alleviates lipopolysaccharide-induced acute lung injury and inflammation through inhibits NF-κB activation.
-
DescriptionEuphorbiafactor?L2?alleviates lipopolysaccharide-induced acute lung injury and inflammation through inhibits NF-κB activation.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayApoptosis
-
TargetNF-κB
-
RecptorNF-κB
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number218916-51-9
-
Formula Weight642.7
-
Molecular FormulaC38H42O9??
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 83.33 mg/mL (129.65 mM)
-
SMILES[H][C@]12C[C@@H](OC(=O)c3ccccc3)C(=C)[C@H](OC(C)=O)[C@@]3([H])[C@@H](OC(=O)c4ccccc4)[C@@H](C)C[C@]3(OC(C)=O)C(=O)\C(C)=C/[C@@]1([H])C2(C)C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Qiuping Z Shuai Z Xiaolan C et al. Euphorbia factor L2 alleviates lipopolysaccharide-induced acute lung injury and inflammation in mice through the suppression of NF-κB activation[J]. Biochemical Pharmacology 2018 155:444-454.
molnova catalog
related products
-
SM-7368
The NF-κB Activation Inhibitor III, controls the biological activity of NF-κB. It is primarily used for Inflammation/Immunology applications.
-
Iguratimod
A novel disease-modifying antirheumatic drug that inhibits NF-kappaB (NF-κB) p65 subunit (RelA) phosphorylation and nuclear translocation without affecting IKBα degradation.
-
BML-190
BML-190 is a specific CB2 receptor inverse agonist (Ki: 435 nM), with 50-fold selectivity over CB1 receptor.
